Canopy Growth (CGC) Free Cash Flow Growth (1y) (2020 - 2025)
Canopy Growth (CGC) Free Cash Flow Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 44.93% |
| 10 | Canopy Growth | 276.52 Mn | 10.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -77.32% |
| Jun 30, 2025 | 79.37% |
| Dec 31, 2024 | 17.11% |
| Sep 30, 2024 | 54.46% |
| Jun 30, 2024 | 49.43% |
| Mar 31, 2024 | -209.45% |
| Dec 31, 2023 | 83.31% |
| Sep 30, 2023 | -42.35% |
| Jun 30, 2023 | 28.11% |
| Mar 31, 2023 | 170.38% |
| Dec 31, 2022 | -9.19% |
| Sep 30, 2022 | 20.73% |
| Jun 30, 2022 | 26.00% |
| Mar 31, 2022 | 88.07% |
| Dec 31, 2021 | -450.20% |
| Sep 30, 2021 | 43.65% |
| Jun 30, 2021 | -16.54% |
| Mar 31, 2021 | 72.19% |
| Dec 31, 2020 | 70.36% |
| Sep 30, 2020 | 13.42% |